Literature DB >> 15225622

Accelerated Abeta aggregation in the presence of GM1-ganglioside-accumulated synaptosomes of aged apoE4-knock-in mouse brain.

Naoki Yamamoto1, Urule Igbabvoa, Yukiko Shimada, Yoshiko Ohno-Iwashita, Mariko Kobayashi, W Gibson Wood, Shinobu C Fujita, Katsuhiko Yanagisawa.   

Abstract

Aging and apolipoprotein E4 (apoE4) expression are strong risk factors for the development of Alzheimer's disease (AD); however, their pathological roles remain to be clarified. In the process of AD development, the conversion of the nontoxic amyloid beta-protein (Abeta) monomer to its toxic aggregates is a fundamental process. We previously hypothesized that Abeta aggregation is accelerated through the generation of GM1 ganglioside (GM1)-bound Abeta which acts as a seed for Abeta fibril formation. Here we report that GM1 level in detergent-resistant membrane microdomains (DRMs) of synaptosomes increased with age and that this increase was significantly pronounced in the apoE4- than the apoE3-knock-in mouse brain. Furthermore, we show that Abeta aggregation is markedly accelerated in the presence of the synaptosomes of the aged apoE4-knock-in mouse brain. These observations suggest that aging and apoE4 expression cooperatively accelerate Abeta aggregation in the brain through an increase in the level of GM1 in neuronal membranes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15225622     DOI: 10.1016/j.febslet.2004.05.037

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

Review 1.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

Review 2.  Is hypercholesterolemia a risk factor for Alzheimer's disease?

Authors:  W Gibson Wood; Urule Igbavboa; Gunter P Eckert; Leslie N Johnson-Anuna; Walter E Müller
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

3.  Neuroprotective effect of ganglioside GM1 on the cytotoxic action of hydrogen peroxide and amyloid beta-peptide in PC12 cells.

Authors:  Tatyana V Sokolova; Irina O Zakharova; Victor V Furaev; Maria P Rychkova; Natalia F Avrova
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

4.  Non-esterified fatty acids generate distinct low-molecular weight amyloid-β (Aβ42) oligomers along pathway different from fibril formation.

Authors:  Amit Kumar; Rebekah L Bullard; Pritesh Patel; Lea C Paslay; Dipti Singh; Ewa A Bienkiewicz; Sarah E Morgan; Vijayaraghavan Rangachari
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

5.  Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling.

Authors:  David A Hicks; Natalia N Nalivaeva; Anthony J Turner
Journal:  Front Physiol       Date:  2012-06-22       Impact factor: 4.566

6.  Weak glycolipid binding of a microdomain-tracer peptide correlates with aggregation and slow diffusion on cell membranes.

Authors:  Tim Lauterbach; Manoj Manna; Maria Ruhnow; Yudi Wisantoso; Yaofeng Wang; Artur Matysik; Kamila Oglęcka; Yuguang Mu; Susana Geifman-Shochat; Thorsten Wohland; Rachel Kraut
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

7.  Aβ1-25-Derived Sphingolipid-Domain Tracer Peptide SBD Interacts with Membrane Ganglioside Clusters via a Coil-Helix-Coil Motif.

Authors:  Yaofeng Wang; Rachel Kraut; Yuguang Mu
Journal:  Int J Mol Sci       Date:  2015-11-03       Impact factor: 5.923

Review 8.  Cross-talk of membrane lipids and Alzheimer-related proteins.

Authors:  Jochen Walter; Gerhild van Echten-Deckert
Journal:  Mol Neurodegener       Date:  2013-10-22       Impact factor: 14.195

Review 9.  Sphingolipids: membrane microdomains in brain development, function and neurological diseases.

Authors:  Anne S B Olsen; Nils J Færgeman
Journal:  Open Biol       Date:  2017-05       Impact factor: 6.411

10.  Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease.

Authors:  Kevin Huynh; Wei Ling Florence Lim; Corey Giles; Kaushala S Jayawardana; Agus Salim; Natalie A Mellett; Adam Alexander T Smith; Gavriel Olshansky; Brian G Drew; Pratishtha Chatterjee; Ian Martins; Simon M Laws; Ashley I Bush; Christopher C Rowe; Victor L Villemagne; David Ames; Colin L Masters; Matthias Arnold; Kwangsik Nho; Andrew J Saykin; Rebecca Baillie; Xianlin Han; Rima Kaddurah-Daouk; Ralph N Martins; Peter J Meikle
Journal:  Nat Commun       Date:  2020-11-10       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.